Lv41
570 积分 2026-02-25 加入
Burden and management of infectious diseases in patients treated by chimeric antigen-receptor T (CAR-T)-cell therapy for refractory or relapsing diffuse large B-cell lymphoma or multiple myeloma
10天前
已关闭
How I Treat Plasma Cell Leukemia
15天前
已完结
On the road to in vivo CAR-T success: Comparing promising viral and non-viral vectors
26天前
已完结
Nanobiomaterials and nucleic acids for CAR-T-based treatment of autoimmune diseases
1个月前
已关闭
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Engineering viral vectors for in vivo CAR-T generation: Advances, challenges, and opportunities
2个月前
已完结
皖公网安备34019202002308
